Skip to content

Clinical trials

Alzheimer Disease trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Ireland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20122
20131
20141
20151
20181
20191
20201
20213
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine3
Eidos Therapeutics, a BridgeBio company2
Eisai Inc.1
H. Lundbeck A/S1
Novo Nordisk A/S1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Prof Brian Lawlor1
Renew Research, LLC1
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1
Tallaght University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease17
Dementia6
Cognitive Dysfunction3
Amyloid Neuropathies, Familial2
Amyloidosis2
Cardiomyopathies2
Heart Diseases2
Memory Disorders2
Cardiovascular Diseases1
Down Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.